Related references
Note: Only part of the references are listed.The multifaceted roles of mitochondria at the crossroads of cell life and death in cancer
Fabrizio Fontana et al.
FREE RADICAL BIOLOGY AND MEDICINE (2021)
Mitochondrial fusion and fission: The fine-tune balance for cellular homeostasis
Mary Adebayo et al.
FASEB JOURNAL (2021)
Therapeutics Targeting the Core Apoptotic Machinery
Claudia Hamilton et al.
CANCERS (2021)
Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation
Hongmei Zheng et al.
CANCERS (2021)
Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer
Miquel Ensenyat-Mendez et al.
FRONTIERS IN ONCOLOGY (2021)
Senescence-Induced Chemoresistance in Triple Negative Breast Cancer and Evolution-Based Treatment Strategies
Anindita Chakrabarty et al.
FRONTIERS IN ONCOLOGY (2021)
Mechanisms Governing Metabolic Heterogeneity in Breast Cancer and Other Tumors
Sayani Patra et al.
FRONTIERS IN ONCOLOGY (2021)
Systemic immunity in cancer
Kamir J. Hiam-Galvez et al.
NATURE REVIEWS CANCER (2021)
Identification of MFGE8 and KLK5/7 as mediators of breast tumorigenesis and resistance to COX-2 inhibition
Jun Tian et al.
BREAST CANCER RESEARCH (2021)
Epithelial-to-mesenchymal transition and invadopodia markers in breast cancer: Lumican a key regulator
Konstantina Karamanou et al.
SEMINARS IN CANCER BIOLOGY (2020)
Involvement of Mitochondrial Mechanisms in the Cytostatic Effect of Desethylamiodarone in B16F10 Melanoma Cells
Fadi H. J. Ramadan et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Amiodarone's major metabolite, desethylamiodarone inhibits proliferation of B16-F10 melanoma cells and limits lung metastasis formation in anin vivoexperimental model
Zita Bognar et al.
PLOS ONE (2020)
Targeting the PI3-kinase pathway in triple-negative breast cancer
J. Pascual et al.
ANNALS OF ONCOLOGY (2019)
Targeting mitochondria as an anticancer strategy
Lanfeng Dong et al.
CANCER COMMUNICATIONS (2019)
Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance
Jayshree Hirpara et al.
REDOX BIOLOGY (2019)
Comparative Profiling of Metastatic 4T1-vs. Non-metastatic Py230-Based Mammary Tumors in an Intraductal Model for Triple-Negative Breast Cancer
Jonas Steenbrugge et al.
FRONTIERS IN IMMUNOLOGY (2019)
Role of mitochondrial function in the invasiveness of human colon cancer cells
Chen-Sung Lin et al.
ONCOLOGY REPORTS (2018)
Mitochondrial membrane potential
Ljubava D. Zorova et al.
ANALYTICAL BIOCHEMISTRY (2018)
Amiodarone's major metabolite, desethylamiodarone, induces apoptosis in human cervical cancer cells
Zita Bognar et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2018)
Oxidative Phosphorylation as an Emerging Target in Cancer Therapy
Thomas M. Ashton et al.
CLINICAL CANCER RESEARCH (2018)
Advances in the systemic treatment of triple-negative breast cancer
J. M. Lebert et al.
CURRENT ONCOLOGY (2018)
Breast cancer subtypes and the risk of distant metastasis at initial diagnosis: a population-based study
Weikai Xiao et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Desethylamiodarone - A metabolite of amiodarone - Induces apoptosis on T24 human bladder cancer cells via multiple pathways
Zita Bognar et al.
PLOS ONE (2017)
Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer
Jun Tian et al.
SCIENTIFIC REPORTS (2017)
Mitochondria, Bioenergetics and Apoptosis in Cancer
Peter J. Burke
TRENDS IN CANCER (2017)
Mitochondria and cancer chemoresistance
Flora Guerra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS (2017)
Targeted therapies in breast cancer: New challenges to fight against resistance
Viviana Masoud et al.
WORLD JOURNAL OF CLINICAL ONCOLOGY (2017)
Metabolic regulation of mitochondrial dynamics
Prashant Mishra et al.
JOURNAL OF CELL BIOLOGY (2016)
Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors
Gao Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Drp1-mediated mitochondrial fission promotes cell proliferation through crosstalk of p53 and NF-κB pathways in hepatocellular carcinoma
Lei Zhan et al.
ONCOTARGET (2016)
Cyclooxygenase-2: A Role in Cancer Stem Cell Survival and Repopulation of Cancer Cells during Therapy
Lisa Y. Pang et al.
STEM CELLS INTERNATIONAL (2016)
Long-term pretreatment with desethylamiodarone (DEA) or amiodarone (AMIO) protects against coronary artery occlusion induced ventricular arrhythmias in conscious rats
Nikolett Morvay et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2015)
Roles of the Cyclooxygenase 2 Matrix Metalloproteinase 1 Pathway in Brain Metastasis of Breast Cancer
Kerui Wu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Targeting mitochondria metabolism for cancer therapy
Samuel E. Weinberg et al.
NATURE CHEMICAL BIOLOGY (2015)
DNA Damage Response Proteins and Oxygen Modulate Prostaglandin E2 Growth Factor Release in Response to Low and High LET Ionizing Radiation
Christopher P. Allen et al.
FRONTIERS IN ONCOLOGY (2015)
Mitochondrial fragmentation impairs insulin-dependent glucose uptake by modulating Akt activity through mitochondrial Ca2+ uptake
Andrea del Campo et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2014)
Prognostic influence of cyclooxygenase-2 protein and mRNA expression in node-negative breast cancer patients
Isabel Sicking et al.
BMC CANCER (2014)
PGC-lα mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis
Valerie S. LeBleu et al.
NATURE CELL BIOLOGY (2014)
Prognostic significance of cyclooxygenase-2 in osteosarcoma: a meta-analysis
Guangjun Jiao et al.
TUMOR BIOLOGY (2013)
Mitochondrial dysfunction in cancer
Michelle L. Boland et al.
FRONTIERS IN ONCOLOGY (2013)
Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer
C. Falandry et al.
ANNALS OF ONCOLOGY (2009)
Mitochondrial DNA is a direct target of anti-cancer anthracycline drugs
Neil Ashley et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Genes that mediate breast cancer metastasis to the brain
Paula D. Bos et al.
NATURE (2009)
Cancer-related inflammation
Alberto Mantovani et al.
NATURE (2008)
Cancer as an overhealing wound:: an old hypothesis revisited
Matthias Schaefer et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
No place like home: anatomy and function of the stem cell niche
D. Leanne Jones et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
A perivascular niche for brain tumor stem cells
Christopher Calabrese et al.
CANCER CELL (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Peroxisome proliferator-activated receptor α activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt
Maja Grabacka et al.
CLINICAL CANCER RESEARCH (2006)
Sulforhodamine B colorimetric assay for cytotoxicity screening
Vanicha Vichai et al.
NATURE PROTOCOLS (2006)
Drug repositioning: Identifying and developing new uses for existing drugs
TT Ashburn et al.
NATURE REVIEWS DRUG DISCOVERY (2004)
Protective effect of amiodarone but not N-desethylamiodarone on postischemic hearts through the inhibition of mitochondrial permeability transition
G Varbiro et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Cyclooxygenase-2 biology
J Claria
CURRENT PHARMACEUTICAL DESIGN (2003)
The phosphatidylinositol 3-kinase-AKT pathway in human cancer
I Vivanco et al.
NATURE REVIEWS CANCER (2002)
Prognostic significance of cyclooxygenase-2 pathway and angiogenesis in head and neck squamous cell carcinoma
O Gallo et al.
HUMAN PATHOLOGY (2002)
The protein kinase B/Akt signalling pathway in human malignancy
KM Nicholson et al.
CELLULAR SIGNALLING (2002)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
